BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 811454)

  • 1. [Dosage of long-term streptokinase fibrinolytic administration (author's transl)].
    Theiss W; Kriessmann A; Wirtzfeld A
    Dtsch Med Wochenschr; 1975 Sep; 100(38):1887-91. PubMed ID: 811454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinolytic therapy in deep venous thrombosis of the upper and lower extremity].
    Kriessmann A; Theiss W; Lutilsky L; Wirtzfeld A; Seifert W; Grünberg G
    Fortschr Med; 1977 Apr; 95(13):858-66. PubMed ID: 844772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
    Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrinolytic treatment of deep venous thromboses with streptokinase at an ultrahigh dosage].
    Theiss W; Baumann G; Klein G
    Dtsch Med Wochenschr; 1987 Apr; 112(17):668-74. PubMed ID: 3569060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of thrombosis in pregnancy (author's transl)].
    Joswig EH; Joswig-Priewe H; Koestering H; Walther C
    Geburtshilfe Frauenheilkd; 1975 Dec; 35(12):932-7. PubMed ID: 1213258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolytic treatment with urokinase (author's transl)].
    Tilsner V; Greul W
    MMW Munch Med Wochenschr; 1975 May; 117(20):865-8. PubMed ID: 124400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H; Auel H; Riedel C
    Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosis.
    van de Loo JC; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Asbeck F; Marbet GA; Schmitt HE; Sewell AF; Duckert F
    Thromb Haemost; 1983 Oct; 50(3):660-3. PubMed ID: 6359570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical treatment of ilio-caval venous thrombosis].
    Serradimigni A; Mathieu P; Sainsous J; Chiche G; Egré A
    Arch Mal Coeur Vaiss; 1981 Mar; 74(3):347-56. PubMed ID: 6782995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aspirin and heparin in the fibrinolytic treatment of acute myocardial infarction].
    López Bescós L
    Rev Esp Cardiol; 1992; 45 Suppl 2():21-8. PubMed ID: 1475505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
    Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
    Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deep venous thrombosis: streptokinase treatment with adaptation of the maintenance dosage].
    Theiss W; Hofer E; Kriessmann A; Lutilsky L; Sauer E; Wirtzfeld A
    Med Klin; 1980 Aug; 75(16):580-6. PubMed ID: 7412703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of heparin and streptokinase in the treatment of venous thrombosis.
    Porter JM; Seaman AJ; Common HH; Rösch J; Eidemiller LR; Calhoun AD
    Am Surg; 1975 Sep; 41(9):511-19. PubMed ID: 1101755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-term lysis of venous thrombosis with ultra-high streptokinase doses].
    Anders O; Lakner V; Konrad H; Ernst B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):82-7. PubMed ID: 2427419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic occlusion of the abdominal aorta in the neonatal period--successful thrombolytic treatment].
    Kaulitz R; Luhmer I; Wilken M; Kallfelz HD
    Klin Padiatr; 1992; 204(3):141-4. PubMed ID: 1614178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinolytic treatment with urokinase and streptokinase for recurrent thrombosis in two valve prostheses for the aortic and mitral valves during pregnancy].
    Tissot H; Vergnes C; Rougier P; Bricaud H; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1093-6. PubMed ID: 1811007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention and therapy of deep venous thromboses in pregnancy].
    Briel RC
    Z Geburtshilfe Perinatol; 1987; 191(5):186-92. PubMed ID: 3433856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of obstruction and thrombosis due to central venous catheterization].
    Leititis JU
    Klin Padiatr; 1991; 203(6):420-3. PubMed ID: 1758144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.